by Dr. Gabe Mirkin | Apr 28, 2019 | Joints & Bones
On April 9, 2019, the U.S. Food and Drug Administration approved a new osteoporosis drug called Evenity. Bones are constantly changed by bone cells called osteoblasts that grow new bone and osteoclasts that remove old bone cells. Evenity is a monoclonal antibody that...
by Dr. Gabe Mirkin | Jan 13, 2019 | Joints & Bones
A review of 47 studies on 22,037 patients with knee osteoarthritis treated for at least 12 months showed no clear difference in controlling long-term pain between medications and placebos (JAMA, 2018;320(24):2564-2579). There was a slight time-limited pain control...
by Dr. Gabe Mirkin | Dec 2, 2018 | Joints & Bones
The majority of people with arthritis are inactive, overweight, diabetic or pre-diabetic. The CDC Morbidity and Mortality Weekly Report (November 9, 2018; 67(44);1238–1241) found that 32 percent of adults with arthritis have pre-diabetes or diabetes, 56.5 percent are...
by Dr. Gabe Mirkin | May 20, 2018 | Joints & Bones
Eighty percent of North Americans have X-ray evidence of osteoarthritis by age 65, and 60 percent have significant joint pain. Osteoarthritis is the most common type of joint pain and since there is no effective treatment, doctors usually just prescribe medications to...
by Dr. Gabe Mirkin | Mar 25, 2018 | Joints & Bones
Hundreds of stem cell clinics in the United States are promoting stem cell treatments for knee osteoarthritis without solid evidence that they help to relieve pain or repair broken cartilage (American Academy of Orthopedic Surgeons March 6, 2018 Annual Meeting in New...
by Dr. Gabe Mirkin | Feb 4, 2018 | Joints & Bones
Eighty percent of North Americans have X-ray evidence of osteoarthritis by age 65, and sixty percent have significant joint pain. More than 700,000 people in the United States have their knees replaced each year. It now looks like inflammation, lack of exercise and...
